SOX2 and how it controls brain support cells (astrocytes)
SOX2-regulated astrocyte homeostasis and pathophysiology
This work looks at how the protein SOX2 helps astrocytes (brain support cells) stay healthy, which could help people with nervous system injuries or diseases.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California at Davis NIH-funded |
| Lab location | 1 site (Davis, United States) |
| Project ID | NIH-11260253 on NIH RePORTER |
What this research studies
They study astrocytes—the brain's support cells—and the protein SOX2 that helps control which genes those cells turn on and off. Using lab models and animal experiments, the team will map the genes SOX2 regulates and watch how astrocytes respond to nerve injury. Methods include genetic manipulation, advanced imaging such as two-photon microscopy, and measuring gene activity to see when astrocytes become protective or harmful. The goal is to link molecular changes in astrocytes to effects on brain function and behavior.
Who could benefit from this research
Good fit: People with demyelinating conditions or other central nervous system injuries would be the most relevant group for future related studies.
Not a fit: Patients with conditions that do not involve central nervous system injury (for example, purely peripheral or non-neurological illnesses) are unlikely to benefit directly from this research.
Why it matters
Potential benefit: If successful, this work could point to new ways to protect or repair the brain in diseases such as demyelinating disorders (for example, multiple sclerosis).
How similar studies have performed: Previous laboratory studies, including work from this group, indicate SOX2 influences astrocyte maturation and function in animals, but moving from these findings to human treatments is still early and largely untested.
Where this research is happening
Davis, United States
- University of California at Davis — Davis, United States (Active)
Researchers
- Principal investigator: Guo, Fuzheng — University of California at Davis
- Study coordinator: Guo, Fuzheng
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.